drugset / Trial / NCT01878136

Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage

NCT01878136

Phase 1/2 Withdrawn Rush University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will evaluate the hypothesis that the administration of intraventricular tPA reduces the rates of cerebral vasospasm and ventriculoperitoneal shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.

Timeline

Start
2015-03
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 1 mg Intravitreal